Literature DB >> 31173578

Decision-making in Orthopaedic Oncology: Does Cognitive Bias Affect a Virtual Patient's Choice Between Limb Salvage and Amputation?

Richard W Gurich1, Amy M Cizik1, Stephanie E Punt2, Michael Namekata2, Christopher N Johnson3, Rebecca G Symons1, Elena G Brewer1, Matthew J Thompson1.   

Abstract

BACKGROUND: The local treatment of extremity sarcomas usually is predicated on a decision between limb salvage and amputation. The manner in which surgical options are presented in the context of shared decision-making may influence this decision. In a population of "simulated" patients-survey respondents presented with a mock clinical vignette and then asked to choose between treatments-we assessed cognitive bias by deliberate alteration of the subjective presentation of the same objective information. QUESTIONS/PURPOSES: (1) Will the manner in which information is presented to a simulated patient, in the setting of treatment for a bone sarcoma, bias their decision regarding pursuing amputation versus limb salvage? (2) At the time of decision-making, will a simulated patient's personal background, demographics, or mood affect their ultimate decision?
METHODS: Survey respondents (Amazon MTurk platform) were presented with mock clinical vignettes simulating a sarcoma diagnosis and were asked to choose between amputation and limb salvage. Specific iterations were designed to assess several described types of cognitive bias. These scenarios were distributed, using anonymous online surveys, to potential participants aged 18 years or older. Recruitment was geographically restricted to individuals in the United States. Overall, 404 respondents completed the survey. The average age of respondents was 33 years (SD 1.2 years), 60% were male and 40% were female. In all, 12% of respondents worked in healthcare. Each respondent also completed questions regarding his or her demographics and his or her current mood. Associations between the type of bias presented and the respondent's choice of limb salvage versus amputation were examined. Independent sample t-tests were used to compare means. Statistical significance was defined as p < 0.05.
RESULTS: When amputation was presented as an option to mitigate functional loss (framing bias), more patients chose it than when limb salvage was presented as means for increased functional gains (23% [23 of 100] versus 10% [12 of 118], odds ratio [OR], 2.26; p = 0.010). Older simulated patients were more likely to choose limb salvage when exposed to framing bias versus younger patients (mean age 33 years versus 30 years, p = 0.02). Respondents who were employed in healthcare more commonly chose amputation versus limb salvage when exposed to framing bias (24% [eight of 35] versus 9% [17 of 183]; OR, 2.46; p = 0.02). Those who chose amputation were more likely to score higher on scales that measured depression or negative affect.
CONCLUSIONS: Shared decision-making in orthopaedic oncology represents a unique circumstance in which several variables may influence a patient's decision between limb salvage and amputation. Invoking cognitive bias in simulated patients appeared to affect treatment decisions. We cannot be sure that these findings translate to the experience of actual sarcoma patients; however, we can conclude that important treatment decisions may be affected by cognitive bias and that patient characteristics (in this study, age, healthcare profession, and mood) may be associated with an individual's susceptibility to cognitive bias. We hope these observations will assist providers in the thoughtful delivery of highly charged information to patients facing difficult decisions, and promote further study of this important concept. LEVEL OF EVIDENCE: Level III, economic and decision analyses.

Entities:  

Mesh:

Year:  2020        PMID: 31173578      PMCID: PMC7145068          DOI: 10.1097/CORR.0000000000000674

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.755


  29 in total

1.  A longitudinal study on emotional adjustment of sarcoma patients: the determinant role of demographic, clinical and coping variables.

Authors:  T Paredes; M Pereira; M R Simões; M C Canavarro
Journal:  Eur J Cancer Care (Engl)       Date:  2011-08-04       Impact factor: 2.520

2.  Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango).

Authors:  C Charles; A Gafni; T Whelan
Journal:  Soc Sci Med       Date:  1997-03       Impact factor: 4.634

3.  What are the Oncologic and Functional Outcomes After Joint Salvage Resections for Juxtaarticular Osteosarcoma About the Knee?

Authors:  Jing Li; Zhen Wang; Chuanlei Ji; Guojing Chen; Dong Liu; Haodong Zhu
Journal:  Clin Orthop Relat Res       Date:  2017-04-19       Impact factor: 4.176

4.  Orthopaedic healthcare worldwide: Shared medical decision making in orthopaedics.

Authors:  Kevin J Bozic
Journal:  Clin Orthop Relat Res       Date:  2013-02-14       Impact factor: 4.176

5.  Functional outcome in amputation versus limb sparing of patients with lower extremity sarcoma: a matched case-control study.

Authors:  A M Davis; M Devlin; A M Griffin; J S Wunder; R S Bell
Journal:  Arch Phys Med Rehabil       Date:  1999-06       Impact factor: 3.966

6.  Psychological outcome of extremity sarcoma survivors undergoing amputation or limb salvage.

Authors:  W W Weddington; K B Segraves; M A Simon
Journal:  J Clin Oncol       Date:  1985-10       Impact factor: 44.544

7.  Treatment preferences of patients and physicians: influences of summary data when framing effects are controlled.

Authors:  D J Mazur; D H Hickam
Journal:  Med Decis Making       Date:  1990 Jan-Mar       Impact factor: 2.583

Review 8.  Understanding patients' decisions. Cognitive and emotional perspectives.

Authors:  D A Redelmeier; P Rozin; D Kahneman
Journal:  JAMA       Date:  1993-07-07       Impact factor: 56.272

9.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

Authors:  M Herdman; C Gudex; A Lloyd; Mf Janssen; P Kind; D Parkin; G Bonsel; X Badia
Journal:  Qual Life Res       Date:  2011-04-09       Impact factor: 4.147

10.  Functional outcome after surgery in patients with bone sarcoma around the knee; results from a long-term prospective study.

Authors:  Janneke C van Egmond-van Dam; W Peter Bekkering; Jos A M Bramer; Auke Beishuizen; Marta Fiocco; P D Sander Dijkstra
Journal:  J Surg Oncol       Date:  2017-04-06       Impact factor: 3.454

View more
  6 in total

1.  CORR Insights®: Which Psychological Variables Are Associated With Pain and Function Before Surgery for de Quervain's Tenosynovitis? A Cross-sectional Study.

Authors:  David Ring
Journal:  Clin Orthop Relat Res       Date:  2019-12       Impact factor: 4.176

2.  CORR Insights®: Clinically Important Reductions in Physical Function and Quality of Life in Adults with Tumor Prostheses in the Hip and Knee: A Cross-sectional Study.

Authors:  Lukas M Nystrom
Journal:  Clin Orthop Relat Res       Date:  2021-10-01       Impact factor: 4.755

3.  CORR Insights®: Decision-making in Orthopaedic Oncology: Does Cognitive Bias Affect a Virtual Patient's Choice Between Limb Salvage and Amputation?

Authors:  Luis Aponte-Tinao
Journal:  Clin Orthop Relat Res       Date:  2020-03       Impact factor: 4.755

4.  From Bench to Bedside: Patience is a Virtue-A Time to Reflect and Reevaluate Surgical Indications.

Authors:  Benjamin K Potter
Journal:  Clin Orthop Relat Res       Date:  2020-09       Impact factor: 4.755

5.  What is the adult experience of Perthes' disease? : initial findings from an international web-based survey.

Authors:  Molly F McGuire; Bella Vakulenko-Lagun; Michael B Millis; Roi Almakias; Earl P Cole; Harry K W Kim
Journal:  Bone Jt Open       Date:  2022-05

6.  Communicating treatment risks and benefits to cancer patients: a systematic review of communication methods.

Authors:  L F van de Water; J J van Kleef; W P M Dijksterhuis; I Henselmans; H G van den Boorn; N M Vaarzon Morel; K F Schut; J G Daams; E M A Smets; H W M van Laarhoven
Journal:  Qual Life Res       Date:  2020-04-24       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.